Newsletter | April 20, 2026

04.20.26 -- Advancing Early Detection In Rare Cancers with Catriona Jamieson, M.D., Ph.D.

FEATURED ARTICLE

Advancing Early Detection In Rare Cancers With Catriona Jamieson, M.D., Ph.D.

On episode 126 of Cell & Gene: The Podcast, Host Erin Harris welcomes Catriona Jamieson, M.D., Ph.D, Director of the UC San Diego Sanford Stem Cell Institute and Professor of Medicine at the School of Medicine.

INDUSTRY INSIGHTS

Why Class 3 Atropisomers Matter: Custom Manufacturing For Oncology Precision

Atropisomers are key to modern small molecule drug development. Learn how advanced manufacturing strategies enable the isolation and scalable production of the most effective single isomer.

A Launchpad For Life Sciences Startups And Entrepreneurs

This company is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.

Unlocking The Benefits Of Site Payment Platforms: Part 1

By standardizing workflows, ensuring audit-ready documentation, and providing actionable real-time insights, these platforms mitigate operational risks while supporting better financial oversight.

Turning Innovation Into Execution In CNS Trials

SCOPE 2026 experts called for practical planning, iterative testing, and real‑world workflows in mental health research, highlighting mock visits, expanded roles, engagement, and psychedelic safety.

How Visualization Turns Clinical Insights Into Action

Explore the critical role of data visualization in clinical research and address the challenges of interpreting fragmented raw data to derive actionable insights that enhance patient outcomes.

Meeting Regulatory And Patient Needs By Improving Clinical Trial Access

Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.

Flexibility And Capability In Pre-Filled Syringes: The Future Of PFS

Explores the benefits of prefilled syringes for drug delivery, including biologics and vaccines, how SARS‑CoV‑2 is accelerating demand, and why partnering with a flexible CDMO drives success.

Connect With Life Science Leader: